Depression and Scopolamine
Join a Research Study: Depression
To find out if you qualify, email NIMH or call 1-877-269-5586 (1-877-MIND-NIH) [TTY: 1-866-411-1010].
NIMH researchers are conducting an inpatient or outpatient treatment study to look at how a currently FDA-approved drug, Scopolamine, which is used for motion sickness, can help with depression. In this study, the drug is given intravenously over 7-sessions.
Eligibility criteria: Ages 18-55, currently depressed, not taking medications for at least 3 weeks.
After completion of the study, NIMH will provide short-term follow-up care, and then you will return to the care of your own provider. In addition, all research participation is without cost and we will cover all transportation costs from anywhere in the United States.
Atendemos pacientes de habla hispana.